Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation

Nobuyuki Tanaka, Takeo Kosaka, Yasumasa Miyazaki, Shuji Mikami, Naoya Niwa, Yutaro Otsuka, Yoji Andrew Minamishima, Ryuichi Mizuno, Eiji Kikuchi, Akira Miyajima, Hisataka Sabe, Yasunori Okada, Per Uhlén, Makoto Suematsu, Mototsugu Oya

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

To identify the molecules involved in epithelial to mesenchymal transition (EMT) in urothelial carcinoma (UC) after acquisition of platinum resistance, here we examined the changes in global gene expression before and after platinum treatment. Four invasive UC cell lines, T24, 5637, and their corresponding sublines T24PR and 5637PR with acquired platinum resistance, were assessed by microarray, and the ubiquitin E3 ligase FBXO32 was newly identified as a negative regulator of EMT in UC tumors after acquisition of platinum resistance. In vitro and in vivo studies showed an intimate relationship between FBXO32 expression and EMT, demonstrating that FBXO32 dysregulation in T24PR cells results in elevated expression of the mesenchymal molecules SNAIL and vimentin and decreased expression of the epithelial molecule E-cadherin. The association between FBXO32 expression and EMT was further validated using clinical samples. Knockdown of MyoD expression, a specific target of FBXO32 polyubiquitination, revealed upregulation of E-cadherin expression and downregulation of SNAIL and vimentin expression in T24PR cells. Comparative genomic hybridization array analysis demonstrated loss of heterozygosity at 8q24.13 in T24PR cells, which harbors FBXO32. Our findings suggest the importance of the association between EMT and ubiquitin-proteasome regulation when tumors develop acquired platinum resistance.

Original languageEnglish
Article numbere83654
JournalJCI Insight
Volume1
Issue number18
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Epithelial-Mesenchymal Transition
Ligases
Ubiquitin
Platinum
Vimentin
Cadherins
Carcinoma
Ubiquitin-Protein Ligases
Comparative Genomic Hybridization
Loss of Heterozygosity
Proteasome Endopeptidase Complex
Neoplasms
Up-Regulation
Down-Regulation
Gene Expression
Cell Line

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation. / Tanaka, Nobuyuki; Kosaka, Takeo; Miyazaki, Yasumasa; Mikami, Shuji; Niwa, Naoya; Otsuka, Yutaro; Minamishima, Yoji Andrew; Mizuno, Ryuichi; Kikuchi, Eiji; Miyajima, Akira; Sabe, Hisataka; Okada, Yasunori; Uhlén, Per; Suematsu, Makoto; Oya, Mototsugu.

In: JCI Insight, Vol. 1, No. 18, e83654, 01.01.2016.

Research output: Contribution to journalArticle

Tanaka, N, Kosaka, T, Miyazaki, Y, Mikami, S, Niwa, N, Otsuka, Y, Minamishima, YA, Mizuno, R, Kikuchi, E, Miyajima, A, Sabe, H, Okada, Y, Uhlén, P, Suematsu, M & Oya, M 2016, 'Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation', JCI Insight, vol. 1, no. 18, e83654. https://doi.org/10.1172/jci.insight.83654
Tanaka, Nobuyuki ; Kosaka, Takeo ; Miyazaki, Yasumasa ; Mikami, Shuji ; Niwa, Naoya ; Otsuka, Yutaro ; Minamishima, Yoji Andrew ; Mizuno, Ryuichi ; Kikuchi, Eiji ; Miyajima, Akira ; Sabe, Hisataka ; Okada, Yasunori ; Uhlén, Per ; Suematsu, Makoto ; Oya, Mototsugu. / Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation. In: JCI Insight. 2016 ; Vol. 1, No. 18.
@article{1c853bb7039d4877999d88c1535f3d99,
title = "Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation",
abstract = "To identify the molecules involved in epithelial to mesenchymal transition (EMT) in urothelial carcinoma (UC) after acquisition of platinum resistance, here we examined the changes in global gene expression before and after platinum treatment. Four invasive UC cell lines, T24, 5637, and their corresponding sublines T24PR and 5637PR with acquired platinum resistance, were assessed by microarray, and the ubiquitin E3 ligase FBXO32 was newly identified as a negative regulator of EMT in UC tumors after acquisition of platinum resistance. In vitro and in vivo studies showed an intimate relationship between FBXO32 expression and EMT, demonstrating that FBXO32 dysregulation in T24PR cells results in elevated expression of the mesenchymal molecules SNAIL and vimentin and decreased expression of the epithelial molecule E-cadherin. The association between FBXO32 expression and EMT was further validated using clinical samples. Knockdown of MyoD expression, a specific target of FBXO32 polyubiquitination, revealed upregulation of E-cadherin expression and downregulation of SNAIL and vimentin expression in T24PR cells. Comparative genomic hybridization array analysis demonstrated loss of heterozygosity at 8q24.13 in T24PR cells, which harbors FBXO32. Our findings suggest the importance of the association between EMT and ubiquitin-proteasome regulation when tumors develop acquired platinum resistance.",
author = "Nobuyuki Tanaka and Takeo Kosaka and Yasumasa Miyazaki and Shuji Mikami and Naoya Niwa and Yutaro Otsuka and Minamishima, {Yoji Andrew} and Ryuichi Mizuno and Eiji Kikuchi and Akira Miyajima and Hisataka Sabe and Yasunori Okada and Per Uhl{\'e}n and Makoto Suematsu and Mototsugu Oya",
year = "2016",
month = "1",
day = "1",
doi = "10.1172/jci.insight.83654",
language = "English",
volume = "1",
journal = "JCI insight",
issn = "2379-3708",
publisher = "The American Society for Clinical Investigation",
number = "18",

}

TY - JOUR

T1 - Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation

AU - Tanaka, Nobuyuki

AU - Kosaka, Takeo

AU - Miyazaki, Yasumasa

AU - Mikami, Shuji

AU - Niwa, Naoya

AU - Otsuka, Yutaro

AU - Minamishima, Yoji Andrew

AU - Mizuno, Ryuichi

AU - Kikuchi, Eiji

AU - Miyajima, Akira

AU - Sabe, Hisataka

AU - Okada, Yasunori

AU - Uhlén, Per

AU - Suematsu, Makoto

AU - Oya, Mototsugu

PY - 2016/1/1

Y1 - 2016/1/1

N2 - To identify the molecules involved in epithelial to mesenchymal transition (EMT) in urothelial carcinoma (UC) after acquisition of platinum resistance, here we examined the changes in global gene expression before and after platinum treatment. Four invasive UC cell lines, T24, 5637, and their corresponding sublines T24PR and 5637PR with acquired platinum resistance, were assessed by microarray, and the ubiquitin E3 ligase FBXO32 was newly identified as a negative regulator of EMT in UC tumors after acquisition of platinum resistance. In vitro and in vivo studies showed an intimate relationship between FBXO32 expression and EMT, demonstrating that FBXO32 dysregulation in T24PR cells results in elevated expression of the mesenchymal molecules SNAIL and vimentin and decreased expression of the epithelial molecule E-cadherin. The association between FBXO32 expression and EMT was further validated using clinical samples. Knockdown of MyoD expression, a specific target of FBXO32 polyubiquitination, revealed upregulation of E-cadherin expression and downregulation of SNAIL and vimentin expression in T24PR cells. Comparative genomic hybridization array analysis demonstrated loss of heterozygosity at 8q24.13 in T24PR cells, which harbors FBXO32. Our findings suggest the importance of the association between EMT and ubiquitin-proteasome regulation when tumors develop acquired platinum resistance.

AB - To identify the molecules involved in epithelial to mesenchymal transition (EMT) in urothelial carcinoma (UC) after acquisition of platinum resistance, here we examined the changes in global gene expression before and after platinum treatment. Four invasive UC cell lines, T24, 5637, and their corresponding sublines T24PR and 5637PR with acquired platinum resistance, were assessed by microarray, and the ubiquitin E3 ligase FBXO32 was newly identified as a negative regulator of EMT in UC tumors after acquisition of platinum resistance. In vitro and in vivo studies showed an intimate relationship between FBXO32 expression and EMT, demonstrating that FBXO32 dysregulation in T24PR cells results in elevated expression of the mesenchymal molecules SNAIL and vimentin and decreased expression of the epithelial molecule E-cadherin. The association between FBXO32 expression and EMT was further validated using clinical samples. Knockdown of MyoD expression, a specific target of FBXO32 polyubiquitination, revealed upregulation of E-cadherin expression and downregulation of SNAIL and vimentin expression in T24PR cells. Comparative genomic hybridization array analysis demonstrated loss of heterozygosity at 8q24.13 in T24PR cells, which harbors FBXO32. Our findings suggest the importance of the association between EMT and ubiquitin-proteasome regulation when tumors develop acquired platinum resistance.

UR - http://www.scopus.com/inward/record.url?scp=85055602863&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055602863&partnerID=8YFLogxK

U2 - 10.1172/jci.insight.83654

DO - 10.1172/jci.insight.83654

M3 - Article

C2 - 27812537

AN - SCOPUS:85055602863

VL - 1

JO - JCI insight

JF - JCI insight

SN - 2379-3708

IS - 18

M1 - e83654

ER -